KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Gains from Investment Securities (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Gains from Investment Securities data on record, last reported at $4.6 million in Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 116.24% year-over-year to $4.6 million; the TTM value through Dec 2025 reached $4.6 million, down 59.69%, while the annual FY2025 figure was $4.6 million, 317.35% up from the prior year.
  • Gains from Investment Securities reached $4.6 million in Q4 2025 per ZBH's latest filing, up from $3.5 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $66.0 million in Q2 2023 and bottomed at -$73.3 million in Q3 2023.
  • Average Gains from Investment Securities over 5 years is $4.5 million, with a median of $3.6 million recorded in 2022.
  • Peak YoY movement for Gains from Investment Securities: soared 11800.0% in 2022, then tumbled 2081.08% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $35.1 million in 2021, then tumbled by 181.2% to -$28.5 million in 2022, then increased by 23.51% to -$21.8 million in 2023, then decreased by 29.82% to -$28.3 million in 2024, then skyrocketed by 116.24% to $4.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $4.6 million in Q4 2025, $3.5 million in Q3 2025, and $300000.0 in Q1 2025.